Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Positive interim phase II data presented for olutasidenib in AML

Oct. 27, 2020

Dual HDAC6/VEGFR-2 inhibitors presented by Beijing Guohong Biomedical Technology

Oct. 27, 2020

Shanghai Synergy Pharmaceutical Sciences, Zhejiang Huahai Pharmaceutical present BRD4 inhibitors

Oct. 27, 2020

ENA 2020: Progress in cancer research can come one mouse at a time, study suggests

Oct. 27, 2020

Shanghai Ringene Biopharma describes new STAT3 inhibitors

Oct. 27, 2020

Olema and Novartis to evaluate OP-1250 in combination therapies

Oct. 27, 2020

KRAS G12C: Adagrasib holds its own at ENA 2020

Oct. 26, 2020

LIDDS' NZ-TLR9 demonstrates antitumoral effect in mouse tumor models

Oct. 26, 2020

Venenum Biodesign synthesizes TREX1 inhibitors

Oct. 26, 2020

Anadolu Ueniversitesi discloses new compounds for cancer

Oct. 26, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...